Trial
NCT00605995
Add-on Simvastatin in Schizophrenia Trial
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
Stanley Medical Research Institute; Sheba Medical Center; Merck Sharp & Dohme LLC
Condition
Schizophrenia
Intervention
Simvastatin
Why stopped
Enrollment was slower than anticipated by the investigators and the funding research foundation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-24